Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-09-000034
Filing Date
2009-11-16
Accepted
2009-11-16 12:02:38
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-093009.htm 10-Q 884461
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16995
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 17012
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6205
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6215
  Complete submission text file 0000318306-09-000034.txt   932508
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 091184828
SIC: 2834 Pharmaceutical Preparations